CoEHAR and ANPVU to Commissioner Kyriakides: ecig as aids for smoking cessation

Prof. Riccardo Polosa, Founder of the CoEHAR, and Carmine Canino, President of  ANPVU, National Association of ecig consumers, have sent a letter to the European Commissioner for Health Stella Kyriakides, regarding her statements on the effectiveness of e-cigarettes to quit smoking.

Continue ReadingCoEHAR and ANPVU to Commissioner Kyriakides: ecig as aids for smoking cessation

Smoking cessation policies in Brazil and UK: the law behind ecig

In a recently published paper, “Health protection, public policies for smoking cessation and regulation of electronic cigarettes in Brazil and the UK: a study of comparative public law”, by Costanza Nicolosi, expert in the economics of legal regulation and Ph.D. in law, the author analyzes the legal approach taken by  two countries, UK and Brazil, in e-cigarettes’ regulation,  marketing, and production

Continue ReadingSmoking cessation policies in Brazil and UK: the law behind ecig
Read more about the article Cigarette smoking and SARS-CoV-2 infection: CoEHAR study found less infected people among current smokers
THE TROINA PROJECT

Cigarette smoking and SARS-CoV-2 infection: CoEHAR study found less infected people among current smokers

CoEHAR researchers investigated for the first time the relationship between biochemically-verified smoking status and SARS-CoV-2 infection in a large population study. The study “The impact of laboratory-verified smoking on SARS-CoV-2 infection: Results from the Troina sero-epidemiological survey”, found that the prevalence of SARS-CoV-2 antibody positivity were reduced in smokers compared to former and never smokers (19.8% vs. 31%)

Continue ReadingCigarette smoking and SARS-CoV-2 infection: CoEHAR study found less infected people among current smokers
Read more about the article Experimental Biology 2022: CoEHAR flies to Philadelphia to present the Replica project
alfio distefano experimental biology

Experimental Biology 2022: CoEHAR flies to Philadelphia to present the Replica project

CoEHAR presented the results of the Replica project during Experimental Biology 2022, the annual meeting that brings together thousands of scientists and experts in the field of anatomy, biochemistry and molecular biology, investigative pathology, pharmacology, and physiology. Representing CoEHAR, the researcher Alfio Distefano, PhD student in neuroscience at the University of Catania

Continue ReadingExperimental Biology 2022: CoEHAR flies to Philadelphia to present the Replica project

CoEHAR exposes for the first time that most e-cigarette research is flawed and in need of urgent critical reform 

Under the leadership of CoEHAR, a team of international researchers, examined the 24 most frequently cited vaping studies published in medical journals. The findings are shocking: almost all of these studies were found to be methodologically flawed; they lacked a clear hypothesis, used inadequate methodology, failed to collect data relevant to the study objectives, and did not correct for obvious confounding factors. 

Continue ReadingCoEHAR exposes for the first time that most e-cigarette research is flawed and in need of urgent critical reform 

International validation of CoEHAR studies: fewer Covid-19 hospitalization among smokers and studies on the role of nicotine

Direct causal relationship between smoking and COVID-19 outcomes: the work of CoEHAR researchers finds confirmations in an english cohort study. Compared with people who had never smoked, current smoking was associated with one-third lower risk of hospitalization

Continue ReadingInternational validation of CoEHAR studies: fewer Covid-19 hospitalization among smokers and studies on the role of nicotine